Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Partial vs Radical Nephrectomy Evaluated

Urol Oncol; ePub 2017 Dec 15; Venkatramani, et al

Partial nephrectomy (PN) resulted in better overall survival than radical nephrectomy (RN) in people with cT1b renal cell carcinoma (RCC), according to a study involving >12,000 individuals. This was not the case in those with cT2 RCC.

Participants with either cT1bN0M0 or cT2N0M0 RCC were identified between 2004 and 2013. They received either partial or radical nephrectomy. Investigators looked at overall survival, 30-day readmission rates, and 30- and 90-day mortality. Among the results:

  • Patients with cT1b tumors who underwent PN experienced better overall survival.
  • Unplanned 30-day readmission rate in patients undergoing PN regardless of tumor type was 4.2%, vs 2.9% for RN.
  • 30- and 90-day mortality rates were similar in the PN and RN cohorts.

Citation:

Venkatramani V, Koru-Sengul T, Miao F, et al. A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry. [Published online ahead of print December 15, 2017]. Urol Oncol. doi:10.1016/j.urolonc.2017.11.008.

This Week's Must Reads

Overall survival factor in metastatic ccRCC, Thiery-Vuillemin A et al. Clinical Genitourinary Cancer 2018; 16: e297-e305

High perirenal fat thickness predicts poor progression-free survival in patients with localized ccRCC, Huang H et al. Urologic Oncology: Seminars and Original Investigations 2018; 36: 157.e1-157.e6

AXL linked to worse outcome of metastatic RCCs treated with sunitinib, Zucca L E et al. Urologic Oncology: Seminars and Original Investigations 2018: 36; 11.e13-11.e21

Pathologic predictors in lymph node dissection of metastatic RCC, Chipollini J et al. Clinical Genitourinary Cancer 2018; 16: Pages e443-450.

Plated-lymphocyte ratio is correlated with poor prognosis in RCC, Wang Z et al. Clinica Chimica Acta; 2018; 480: 166-72.

Must Reads in Renal Cell Carcinoma

Overall survival factor in metastatic ccRCC, Thiery-Vuillemin A et al. Clinical Genitourinary Cancer 2018; 16: e297-e305

High perirenal fat thickness predicts poor progression-free survival in patients with localized ccRCC, Huang H et al. Urologic Oncology: Seminars and Original Investigations 2018; 36: 157.e1-157.e6

AXL linked to worse outcome of metastatic RCCs treated with sunitinib, Zucca L E et al. Urologic Oncology: Seminars and Original Investigations 2018: 36; 11.e13-11.e21

Pathologic predictors in lymph node dissection of metastatic RCC, Chipollini J et al. Clinical Genitourinary Cancer 2018; 16: Pages e443-450.

Plated-lymphocyte ratio is correlated with poor prognosis in RCC, Wang Z et al. Clinica Chimica Acta; 2018; 480: 166-72.